Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs

International Journal of Experimental Pathology

Volumn 90, Issue 4, 2009, Pages 431-438

  Olivier, Alicia ^a   Gallup, Jack ^a   De MacEdo, Marcia M M A ^a   Varga, Steven M ^b   Ackermann, Mark ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Defensin; Innate immunity; Pulmonary; Respiratory syncytial virus; Surfactant protein; Thyroid transcription factor

Indexed keywords

BETA DEFENSIN 1; MESSENGER RNA; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; THYROID TRANSCRIPTION FACTOR 1; VIRUS ANTIGEN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; INOCULATION; INTERSTITIAL PNEUMONIA; LUNG LESION; NEUTROPHIL; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, VIRAL; BETA-DEFENSINS; BIOLOGICAL MARKERS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; MODELS, ANIMAL; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RANDOM ALLOCATION; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RNA, MESSENGER; SHEEP; SHEEP DISEASES; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 68849114192     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00643.x     Document Type: Article

References (36)

1. Abraham W.M. (2008) Modeling of asthma, COPD and cystic fibrosis in sheep. Pulm. Pharmacol. Ther. 21, 743 754.
2. Bals R. Hiemstra P.S. (2004) Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23, 327 333.
3. Besnard V., Xu Y., Whitsett J.A. (2007) Sterol response element binding protein and thyroid transcription factor-1 (Nkx2.1) regulate Abca3 gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1395 L1405.
4. Dave V., Childs T., Whitsett J.A. (2004) Nuclear factor of activated T cells regulates transcription of the surfactant protein D gene (Sftpd) via direct interaction with thyroid transcription factor-1 in lung epithelial cells. J. Biol. Chem. 279, 34578 34588.
5. Davey M.G., Biard J.M., Robinson L. et al. (2005) Surfactant protein expression is increased in the ipsilateral but not contralateral lungs of fetal sheep with left-sided diaphragmatic hernia. Pediatr. Pulmonol. 39, 359 367.
6. DeFelice M., Silberschmidt D., DiLauro R. et al. (2003) TTF-1 phosphorylation is required for peripheral lung morphogenesis, perinatal survival, and tissue-specific gene expression. J. Biol. Chem. 278, 35574 35583.
7. Flecknoe S.J., Wallace M.J., Cock M.L., Harding R., Hooper S.B. (2003) Changes in alveolar epithelial cell proportions during fetal and postnatal development in sheep. Am. J. Physiol. Lung Cell. Mol. Physiol. 285, L664 L670.
8. Gallup J.M. Ackermann M.R. (2006) Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system 'FocusField2-6GallupqPCRSet- upTool-001' to attain consistently high fidelity qPCR reactions. Biol. Proced. Online 8, 87 152.
9. Gilca R., De Serres G., Tremblay M. et al. (2006) Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. J. Infect. Dis. 193, 54 58.
10. Grubor B., Gallup J.M., Meyerholz D.K. et al. (2004) Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs. Clin. Diagn. Lab. Immunol. 11, 599 607.
11. Hickling T.P., Clark H., Malhotra R., Sim R.B. (2004) Collectins and their role in lung immunity. J. Leukoc. Biol. 75, 27 33.
12. Hu A., Colella M., Tam J.S., Rappaport R., Cheng S.M. (2003) Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. J. Clin. Microbiol. 41, 149 154.
13. Johnson J.E., Gonzales R.A., Olson S.J., Wright P.F., Graham B.S. (2007) The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 20, 108 119.
14. Kawashima K., Meyerholz D.K., Gallup J.M. et al. (2006) Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus. Viral Immunol. 19, 316 323.
15. Kerr M.H. Paton J.Y. (1999) Surfactant protein levels in severe respiratory syncytial virus infection. Am. J. Respir. Crit. Care Med. 159, 1115 1118.
16. Kong X., Hellermann G.R., Patton G. et al. (2005) An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Virol J. 2, 3.
17. Lahti M., Lofgren J., Marttila R. et al. (2002) Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr. Res. 51, 696 699. (Pubitemid 34547331)
18. Langston C., Kida K., Reed M., Thurlbeck W.M. (1984) Human lung growth in late gestation and in the neonate. Am. Rev. Respir. Dis. 129, 607 613.
19. Lapin C.D., Hiatt P.W., Langston C., Mason E., Piedra P.T. (1993) A lamb model for human respiratory syncytial virus infection. Pediatr. Pulmonol. 15, 151 156.
20. Lehmkuhl H.D. Cutlip R.C. (1979) Experimentally induced respiratory syncytial viral infection in lambs. Am. J. Vet. Res. 40, 512 544.
21. LeVine A.M., Elliott J., Whitsett J.A. et al. (2004) Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 31, 193 199.
22. Mariassy A.T. Plopper C.G. (1983) Tracheobronchial epithelium of the sheep: I. Quantitative light-microscopic study of epithelial cell abundance, and distribution. Anat. Rec. 205, 263 275.
23. Meyerholz D.K., Grubor B., Fach S.J. et al. (2004) Reduced clearance of respiratory syncytial virus infection in a preterm lamb model. Microbes Infect. 6, 1312 1319.
24. Meyerholz D.K., Kawashima K., Gallup J.M., Grubor B., Ackermann M.R. (2006) Expression of select immune genes (surfactant proteins A and D, sheep beta defensin 1, and toll-like receptor 4) by respiratory epithelia is developmentally regulated in the preterm neonatal lamb. Dev. Comp. Immunol. 30, 1060 1069.
25. Murata Y. Falsey A.R. (2007) Respiratory syncytial virus infection in adults. Antivir. Ther. 12, 659 670.
26. Pack R.J., Al-Ugaily L.H., Morris G. (1981) The cells of the tracheobronchial epithelium of the mouse: a quantitative light and electron microscope study. J. Anat. 132, 71 84.
27. Pastva A.M., Wright J.R., Williams K.L. (2007) Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc. Am. Thorac. Soc. 4, 252 257.
28. Sano H. Kuroki Y. (2005) The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol. Immunol. 42, 279 287.
29. Scheerlinck J.P., Snibson K.J., Bowles V.M., Sutton P. (2008) Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol. 26, 259 266.
30. Scheuermann D.W., Van Meir F., Adriaensen D., Timmermans J.P., De Groodt-Lasseel M.H. (1988) Development of alveolar septa and formation of alveolar pores during the early postnatal period in the rat lung. Acta Anat. (Basel) 131, 249 261.
31. Schutte B.C. McCray P.B. Jr. (2002) [beta]-defensins in lung host defense. Annu. Rev. Physiol. 64, 709 748.
32. Shay D.K., Holman R.C., Newman R.D., Liu L.L., Stout J.W., Anderson L.J. (1999) Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282, 1440 1446.
33. Starner T.D., Barker C.K., Jia H.P., Kang Y., McCray P.B. Jr. (2003) CCL20 is an inducible product of human airway epithelia with innate immune properties. Am. J. Respir. Cell Mol. Biol. 29, 627 633.
34. Starner T.D., Agerberth B., Gudmundsson G.H., McCray P.B. Jr. (2005) Expression and activity of beta-defensins and LL-37 in the developing human lung. J. Immunol. 174, 1608 1615.
35. Welliver R.C. (2003) Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J. Pediatr. 143, S112 S117.
36. Welliver T.P., Garofalo R.P., Hosakote Y. et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195, 1126 1136.